메뉴 건너뛰기




Volumn 25, Issue 12, 2014, Pages 2425-2432

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: Pooled analysis of two STBSG-EORTC phase III clinical trials

(18)  Le Cesne, A a   Ouali, M b   Leahy, M G c   Santoro, A d   Hoekstra, H J e   Hohenberger, P f   Van Coevorden, F g   Rutkowski, P h   Van Hoesel, R i   Verweij, J j   Bonvalot, S a   Steward, W P c   Gronchi, A d   Hogendoorn, P C W k   Litiere, S b   Marreaud, S b   Blay, J Y l   Van Der Graaf, W T A i  


Author keywords

Adjuvant chemotherapy; Predictive factors; Soft tissue sarcoma; Treatment outcome

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC;

EID: 84924414501     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu460     Document Type: Article
Times cited : (124)

References (37)
  • 1
    • 84866596020 scopus 로고    scopus 로고
    • ESMO clinical practice guidelines for diagnosis, treatment and follow-up
    • Soft tissue and visceral sarcoma. ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012; 23(suppl 7): 92-99.
    • (2012) Annals of Oncology , vol.23 , pp. 92-99
  • 2
    • 80155150199 scopus 로고    scopus 로고
    • Sarcomas of the soft tissue and bone
    • Devita VT, Lawrence TS, Rosenberg SA (eds), 8th edition. Philadelphia: Lippincott Williams and Wilkins
    • Brennan MF, Singer S, Maki R et al. Sarcomas of the soft tissue and bone. In Devita VT, Lawrence TS, Rosenberg SA (eds). Cancer Principles and Practice of Oncology, 8th edition. Philadelphia: Lippincott Williams and Wilkins 2008; 1741-1794.
    • (2008) Cancer Principles and Practice of Oncology , pp. 1741-1794
    • Brennan, M.F.1    Singer, S.2    Maki, R.3
  • 3
    • 77649144152 scopus 로고    scopus 로고
    • Extremity soft tissue sarcoma in a series of patients treated at a single institution
    • Gronchi A, Lo Vullo S, Colombo C et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution. Ann Surg 2010; 251: 512-517.
    • (2010) Ann Surg , vol.251 , pp. 512-517
    • Gronchi, A.1    Lo Vullo, S.2    Colombo, C.3
  • 4
    • 58149353006 scopus 로고    scopus 로고
    • Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control
    • Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27(1): 31-37.
    • (2009) J Clin Oncol , vol.27 , Issue.1 , pp. 31-37
    • Bonvalot, S.1    Rivoire, M.2    Castaing, M.3
  • 6
    • 0037216150 scopus 로고    scopus 로고
    • Advanced soft tissue sarcoma: a disease that a potentially curable subset of patients treated with chemotherapy
    • Blay JY, Van Glabbeke M, Verweij J et al. Advanced soft tissue sarcoma: a disease that a potentially curable subset of patients treated with chemotherapy. Eur J Cancer 2003; 39: 64-69.
    • (2003) Eur J Cancer , vol.39 , pp. 64-69
    • Blay, J.Y.1    Van Glabbeke, M.2    Verweij, J.3
  • 7
    • 0031566814 scopus 로고    scopus 로고
    • Sarcoma Meta-Analysis Collaboration
    • Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-Analysis Collaboration. Lancet 1997; 350: 1647-1654.
    • (1997) Lancet , vol.350 , pp. 1647-1654
  • 8
    • 0000862573 scopus 로고
    • A systematic overview and quantitative metaanalysis
    • Jones GW, Chouinard M, Patel M. A systematic overview and quantitative metaanalysis. Clin Invest Med 1991; 14(suppl 19): A772.
    • (1991) Clin Invest Med , vol.14
    • Jones, G.W.1    Chouinard, M.2    Patel, M.3
  • 9
    • 0002611831 scopus 로고
    • Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities
    • Salmon SE (ed). Philadelphia: JB Lippincott
    • Zalupski MM, Ryan JR, Hussein ME et al. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In Salmon SE (ed). Adjuvant Therapy of Cancer VII. Philadelphia: JB Lippincott 1993; 385-392.
    • (1993) Adjuvant Therapy of Cancer VII , pp. 385-392
    • Zalupski, M.M.1    Ryan, J.R.2    Hussein, M.E.3
  • 10
    • 0029087491 scopus 로고
    • Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
    • Tierney JF, Mosseri V, Stewart LA et al. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995; 72: 469-475.
    • (1995) Br J Cancer , vol.72 , pp. 469-475
    • Tierney, J.F.1    Mosseri, V.2    Stewart, L.A.3
  • 11
    • 0035282058 scopus 로고    scopus 로고
    • Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian Randomised Cooperative Trial
    • Frustaci S, Gherlinzoni F, De Paoli A et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian Randomised Cooperative Trial. J Clin Oncol 2001; 19: 1238-1247.
    • (2001) J Clin Oncol , vol.19 , pp. 1238-1247
    • Frustaci, S.1    Gherlinzoni, F.2    De Paoli, A.3
  • 12
    • 16544363434 scopus 로고    scopus 로고
    • Cohort analysis of patients with localized, highrisk, extremity soft-tissue sarcoma treated at two cancer centers: chemotherapyassociated outcomes
    • Cormier JN, Huang X, Xing Y et al. Cohort analysis of patients with localized, highrisk, extremity soft-tissue sarcoma treated at two cancer centers: chemotherapyassociated outcomes. J Clin Oncol 2004; 22: 4567-4574.
    • (2004) J Clin Oncol , vol.22 , pp. 4567-4574
    • Cormier, J.N.1    Huang, X.2    Xing, Y.3
  • 13
    • 0034527930 scopus 로고    scopus 로고
    • Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial
    • Brodowicz T, Schwameis E, Widder J et al. Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma 2000; 4: 151-160.
    • (2000) Sarcoma , vol.4 , pp. 151-160
    • Brodowicz, T.1    Schwameis, E.2    Widder, J.3
  • 14
    • 0036793736 scopus 로고    scopus 로고
    • Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
    • Petrioli R, Coratti A, Correale P et al. Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 2002, 25(5): 468-473.
    • (2002) Am J Clin Oncol , vol.25 , Issue.5 , pp. 468-473
    • Petrioli, R.1    Coratti, A.2    Correale, P.3
  • 15
    • 84984909046 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with doxorubicin, ifosfamide and lenograstim for resected soft tissue sarcoma
    • Woll PJ, Reicheardt P, Le Cesne A et al. Adjuvant chemotherapy with doxorubicin, ifosfamide and lenograstim for resected soft tissue sarcoma. Lancet Oncol 2012; 12: 1470.
    • (2012) Lancet Oncol , vol.12 , pp. 1470
    • Woll, P.J.1    Reicheardt, P.2    Le Cesne, A.3
  • 16
    • 49049089340 scopus 로고    scopus 로고
    • A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
    • Pervaiz N, Colterjohn N, Farrokhyar F et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 573-581.
    • (2008) Cancer , vol.113 , pp. 573-581
    • Pervaiz, N.1    Colterjohn, N.2    Farrokhyar, F.3
  • 17
    • 0028334634 scopus 로고
    • Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    • Bramwell V, Rouesse J, Steward W. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994; 12: 1137-1149.
    • (1994) J Clin Oncol , vol.12 , pp. 1137-1149
    • Bramwell, V.1    Rouesse, J.2    Steward, W.3
  • 18
    • 33750492907 scopus 로고    scopus 로고
    • Function preserving surgery of limb sarcomas: history and improvements
    • Bonvalot S, Missana MC, Le Cesne A et al. Function preserving surgery of limb sarcomas: history and improvements. Cancer Radiother 2006; 10(6-7): 416-424.
    • (2006) Cancer Radiother , vol.10 , Issue.6-7 , pp. 416-424
    • Bonvalot, S.1    Missana, M.C.2    Le Cesne, A.3
  • 19
    • 84867402175 scopus 로고    scopus 로고
    • Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG
    • Bonvalot S, Raut CP, Pollock RE et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19(9): 2981-2991.
    • (2012) Ann Surg Oncol , vol.19 , Issue.9 , pp. 2981-2991
    • Bonvalot, S.1    Raut, C.P.2    Pollock, R.E.3
  • 20
    • 0029913782 scopus 로고    scopus 로고
    • Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities
    • Pisters PW, Leung DH, Woodruff J et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689.
    • (1996) J Clin Oncol , vol.14 , pp. 1679-1689
    • Pisters, P.W.1    Leung, D.H.2    Woodruff, J.3
  • 21
    • 0035873187 scopus 로고    scopus 로고
    • Predictive value of grade for metastasis development in the main histological types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group
    • Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histological types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-1926.
    • (2001) Cancer , vol.91 , pp. 1914-1926
    • Coindre, J.M.1    Terrier, P.2    Guillou, L.3
  • 22
    • 0032952928 scopus 로고    scopus 로고
    • Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracyclin-containing first-line regimens-a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
    • Van Glabekke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracyclin-containing first-line regimens-a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150-157.
    • (1999) J Clin Oncol , vol.17 , pp. 150-157
    • Van Glabekke, M.1    van Oosterom, A.T.2    Oosterhuis, J.W.3
  • 23
    • 78649491471 scopus 로고    scopus 로고
    • Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
    • Italiano A, Delva F, Mathoulin-Pelissier S et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann Oncol 2010; 21(12): 2436-2441.
    • (2010) Ann Oncol , vol.21 , Issue.12 , pp. 2436-2441
    • Italiano, A.1    Delva, F.2    Mathoulin-Pelissier, S.3
  • 24
    • 62849096370 scopus 로고    scopus 로고
    • Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, double-blind, placebo-controlled trial
    • De Matteo RP, Ballman KV, Antonescu CR et al. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, double-blind, placebo-controlled trial. Lancet 2009; 373(9669): 1097-1104.
    • (2009) Lancet , vol.373 , Issue.9669 , pp. 1097-1104
    • De Matteo, R.P.1    Ballman, K.V.2    Antonescu, C.R.3
  • 25
    • 84859187987 scopus 로고    scopus 로고
    • One versus three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
    • Joensuu H, Eriksson M, Sundby Hall K et al. One versus three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 2012; 307(12): 1265-1272.
    • (2012) JAMA , vol.307 , Issue.12 , pp. 1265-1272
    • Joensuu, H.1    Eriksson, M.2    Sundby Hall, K.3
  • 26
    • 84879968987 scopus 로고    scopus 로고
    • Adhesion to clinical practices guidelines (CPG's) and role on survival for tissue sarcoma patients. Analysis of a population based cohort from Rhone-Alpes region
    • Derbel O, Cropet C, Meeus P et al. Adhesion to clinical practices guidelines (CPG's) and role on survival for tissue sarcoma patients. Analysis of a population based cohort from Rhone-Alpes region. Ann Oncol 2012; 23(suppl 9): 478-491.
    • (2012) Ann Oncol , vol.23 , pp. 478-491
    • Derbel, O.1    Cropet, C.2    Meeus, P.3
  • 27
    • 84906332168 scopus 로고    scopus 로고
    • Prospective web-based collection of sarcoma cases diagnosed and treated in France: experience of the NetSarc network of the French Sarcoma Tumor Boards
    • Ducimetière F, Blay JY, Le Cesne A et al. Prospective web-based collection of sarcoma cases diagnosed and treated in France: experience of the NetSarc network of the French Sarcoma Tumor Boards. J Clin Oncol 2012; 30(suppl); abstr 10056.
    • (2012) J Clin Oncol , vol.30
    • Ducimetière, F.1    Blay, J.Y.2    Le Cesne, A.3
  • 28
    • 84875466344 scopus 로고    scopus 로고
    • Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
    • Lagarde P, Przybyl J, Brulard C et al. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. J Clin Oncol 2013; 31: 1-9.
    • (2013) J Clin Oncol , vol.31 , pp. 1-9
    • Lagarde, P.1    Przybyl, J.2    Brulard, C.3
  • 29
    • 73349100029 scopus 로고    scopus 로고
    • Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven adjuvant CT
    • Blay JY, Le Cesne A. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven adjuvant CT. Oncologist 2009; 14: 1013-1020.
    • (2009) Oncologist , vol.14 , pp. 1013-1020
    • Blay, J.Y.1    Le Cesne, A.2
  • 30
    • 77954535843 scopus 로고    scopus 로고
    • Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
    • Chibon F, Lagarde P, Salas S et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010; 16(7): 781-788.
    • (2010) Nat Med , vol.16 , Issue.7 , pp. 781-788
    • Chibon, F.1    Lagarde, P.2    Salas, S.3
  • 31
    • 79957579501 scopus 로고    scopus 로고
    • Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissue sarcoma
    • Ruiz-Soto R, Auger N, Tournay E et al. Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissue sarcoma. Eur J Cancer 2011; 47: 1319-1327.
    • (2011) Eur J Cancer , vol.47 , pp. 1319-1327
    • Ruiz-Soto, R.1    Auger, N.2    Tournay, E.3
  • 32
    • 20844433223 scopus 로고    scopus 로고
    • Progression-free survival in gastrointestinal stromal tumours with high dose imatinib: randomized trial
    • Verweij J, Casali GP et al. Progression-free survival in gastrointestinal stromal tumours with high dose imatinib: randomized trial. Lancet 2004; 364: 1127-1134.
    • (2004) Lancet , vol.364 , pp. 1127-1134
    • Verweij, J.1    Casali, G.P.2
  • 33
    • 77950469922 scopus 로고    scopus 로고
    • Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials
    • Rutkowski P, Van Glabbeke M, Rankin CJ et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol 2010; 28(10): 1772-1778.
    • (2010) J Clin Oncol , vol.28 , Issue.10 , pp. 1772-1778
    • Rutkowski, P.1    Van Glabbeke, M.2    Rankin, C.J.3
  • 34
    • 77349120482 scopus 로고    scopus 로고
    • Denosumab in patients with giant-cell tumor of bone: a open-label phase II
    • Thomas D, Henshaw R, Skubitz K et al. Denosumab in patients with giant-cell tumor of bone: a open-label phase II. Lancet Oncol 2010; 11: 275-280.
    • (2010) Lancet Oncol , vol.11 , pp. 275-280
    • Thomas, D.1    Henshaw, R.2    Skubitz, K.3
  • 35
    • 84857530639 scopus 로고    scopus 로고
    • Phase II clinical trial of neo-adjuvant trabectedin in patients with advanced localized myxoid liposarcoma
    • Gronchi A, Bui NB, Bonvalot S et al. Phase II clinical trial of neo-adjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol 2012; 23: 771-776.
    • (2012) Ann Oncol , vol.23 , pp. 771-776
    • Gronchi, A.1    Bui, N.B.2    Bonvalot, S.3
  • 36
    • 84882955940 scopus 로고    scopus 로고
    • Cediranib for metastatic alveolar soft part sarcoma
    • Kummar S, Allen D, Monks A et al. Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol 2013; 18: 2296-2302.
    • (2013) J Clin Oncol , vol.18 , pp. 2296-2302
    • Kummar, S.1    Allen, D.2    Monks, A.3
  • 37
    • 84861098484 scopus 로고    scopus 로고
    • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double blind, placebo-controlled phase III trial
    • Van Der Graaf WTA, Blay JY, Chawla SP et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double blind, placebo-controlled phase III trial. Lancet Oncol 2012; 379: 1879-1886.
    • (2012) Lancet Oncol , vol.379 , pp. 1879-1886
    • Van Der Graaf, W.T.A.1    Blay, J.Y.2    Chawla, S.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.